What this means
This is a study plan to test whether IV infusions of donor umbilical cord stem cells are safe for frailty. It is still recruiting, and no results have been posted yet.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- See eligibility
- Where
- 3 sites
The science
- Registered title
- Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Aging Frailty
- Trial ID
- NCT05018767 ↗
- Phase
- PHASE 1
- Study type
- interventional
- Conditions
- Frailty
- What is tested
- AlloRx
- Sponsor
- The Foundation for Orthopaedics and Regenerative Medicine
- Ages
- No minimum to no maximum
- Dates
- First posted Aug 24, 2021 · updated Apr 4, 2025
Registry summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Aging Frailty
Sites (3)
- Medical Surgical Associates Center, St John's, Antigua and Barbuda
- Athens Beverly Hills Medical Group, Glyfada, Athens, Greece
- Artros, Ljubljana, Slovenia, Slovenia